(Reuters) - Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less ...

Pfizer (NYSE:PFE) has agreed to a settlement deal for antitrust claims regarding its cholesterol drug Lipitor, according to a filing in the U.S. court in Trenton, New Jersey. The drugmaker will pay ...

(Reuters) - Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of generic versions of ...

Ranbaxy Laboratories Limited, announced today that it has made an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving the cholesterol-lowering medicine ...

(Reuters) - Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug ...

Pfizer (PFE) has been hot lately, up 22 percent since December of last year and only 5 percent off its 52-week high reached at the end of May. However, one could say that its about to have its profits ...

New York, NY - Pfizer has announced that it is ending its US promotional activities for its branded statin, Lipitor (atorvastatin). The product lost its patent protection in the US last November, but ...

Feb 14 (Reuters) - Pfizer PFE.N has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales ...